ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 155 filers reported holding ANTARES PHARMA INC in Q1 2020. The put-call ratio across all filers is 347.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $55,000 | +1.9% | 13,500 | 0.0% | 0.00% | – |
| Q4 2020 | $54,000 | +50.0% | 13,500 | 0.0% | 0.00% | – |
| Q3 2020 | $36,000 | -2.7% | 13,500 | 0.0% | 0.00% | – |
| Q2 2020 | $37,000 | +15.6% | 13,500 | 0.0% | 0.00% | – |
| Q1 2020 | $32,000 | -49.2% | 13,500 | 0.0% | 0.00% | – |
| Q4 2019 | $63,000 | +40.0% | 13,500 | 0.0% | 0.00% | – |
| Q3 2019 | $45,000 | +2.3% | 13,500 | 0.0% | 0.00% | – |
| Q2 2019 | $44,000 | +7.3% | 13,500 | -0.4% | 0.00% | – |
| Q1 2019 | $41,000 | +10.8% | 13,553 | 0.0% | 0.00% | – |
| Q4 2018 | $37,000 | -24.5% | 13,553 | -7.8% | 0.00% | – |
| Q3 2018 | $49,000 | +40.0% | 14,694 | +6.8% | 0.00% | – |
| Q2 2018 | $35,000 | +16.7% | 13,753 | +1.9% | 0.00% | – |
| Q1 2018 | $30,000 | +11.1% | 13,500 | 0.0% | 0.00% | – |
| Q4 2017 | $27,000 | -64.5% | 13,500 | -42.6% | 0.00% | – |
| Q3 2017 | $76,000 | -10.6% | 23,500 | -11.3% | 0.00% | – |
| Q2 2017 | $85,000 | +13.3% | 26,500 | 0.0% | 0.00% | – |
| Q1 2017 | $75,000 | +21.0% | 26,500 | 0.0% | 0.00% | – |
| Q4 2016 | $62,000 | +34.8% | 26,500 | -2.9% | 0.00% | – |
| Q3 2016 | $46,000 | +58.6% | 27,300 | 0.0% | 0.00% | – |
| Q2 2016 | $29,000 | +20.8% | 27,300 | 0.0% | 0.00% | – |
| Q1 2016 | $24,000 | -11.1% | 27,300 | +22.4% | 0.00% | – |
| Q4 2015 | $27,000 | +200.0% | 22,300 | +346.0% | 0.00% | – |
| Q3 2015 | $9,000 | -35.7% | 5,000 | 0.0% | 0.00% | – |
| Q1 2015 | $14,000 | +7.7% | 5,000 | 0.0% | 0.00% | – |
| Q4 2014 | $13,000 | +44.4% | 5,000 | 0.0% | 0.00% | – |
| Q3 2014 | $9,000 | +50.0% | 5,000 | +127.3% | 0.00% | – |
| Q2 2014 | $6,000 | -93.5% | 2,200 | -91.6% | 0.00% | -100.0% |
| Q1 2014 | $92,000 | +820.0% | 26,200 | +1090.9% | 0.00% | – |
| Q4 2013 | $10,000 | -54.5% | 2,200 | -58.8% | 0.00% | – |
| Q3 2013 | $22,000 | +100.0% | 5,346 | +98.0% | 0.00% | – |
| Q2 2013 | $11,000 | – | 2,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 6,400,000 | $13,312,000 | 4.78% |
| GREAT POINT PARTNERS LLC | 2,800,000 | $5,824,000 | 2.27% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 18,389,789 | $38,251,000 | 1.27% |
| WILLIAM HARRIS INVESTORS INC | 1,534,283 | $3,191,000 | 0.89% |
| Broadfin Capital, LLC | 7,575,000 | $15,756,000 | 0.85% |
| Lombard Odier Asset Management (USA) Corp | 1,000,000 | $2,080,000 | 0.15% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,665,738 | $3,465,000 | 0.14% |
| JW Asset Management, LLC | 142,198 | $296,000 | 0.09% |
| Donald L. Hagan, LLC | 44,000 | $92,000 | 0.09% |
| DAFNA Capital Management LLC | 45,000 | $94,000 | 0.08% |